A randomized pilot trial of growth hormone with anastrozole versus growth hormone alone, starting at the very end of puberty in adolescents with idiopathic short stature

BACKGROUND: When given during the course of puberty, anastrozole (A), an aromatase inhibitor, has been shown to increase the predicted adult height (PAH) of GH-deficient (GHD) boys treated with recombinant human growth hormone (rhGH). Our study questioned whether this treatment could retain some of...

Descripción completa

Detalles Bibliográficos
Autores principales: Rothenbuhler, Anya, Linglart, Agnès, Bougnères, Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4429943/
https://www.ncbi.nlm.nih.gov/pubmed/25972902
http://dx.doi.org/10.1186/1687-9856-2015-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4429943/
https://www.ncbi.nlm.nih.gov/pubmed/25972902
http://dx.doi.org/10.1186/1687-9856-2015-4

Ejemplares similares